The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Genentech; Prometheus
Speakers' Bureau - Astellas Pharma; Janssen; Novartis; Pfizer; Sanofi
Research Funding - Exelixis; Genentech; Janssen
Updated efficacy and > 1-y follow up from IMvigor210: Atezolizumab (atezo) in platinum (plat) treated locally advanced/metastatic urothelial carcinoma (mUC).
 
Robert Dreicer
Honoraria - Astellas Pharma
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; BIND Biosciences; Dendreon; Medivation; Merck; Millennium; Roche
Research Funding - Progenics (Inst)
 
Jean H. Hoffman-Censits
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Sanofi
Travel, Accommodations, Expenses - Roche/Genentech
 
Thomas W. Flaig
Leadership - Aurora Oncology
Stock and Other Ownership Interests - Aurora Oncology
Honoraria - BN ImmunoTherapeutics; GTx
Consulting or Advisory Role - GTX
Research Funding - Aragon Pharmaceuticals; Bavarian Nordic; Bristol-Myers Squibb; Cougar Biotechnology; Dendreon; Exelixis; GTx; Janssen Oncology; Medivation; Novartis; Pfizer; Roche/Genentech; Sanofi; Sotio
Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents in which I am an inventor. These are related to bladder cancer treatment of early stage disease.
Travel, Accommodations, Expenses - Bavarian Nordic; GTx
 
Enrique Grande
No Relationships to Disclose
 
Ani Sarkis Balmanoukian
No Relationships to Disclose
 
Gunhild von Amsberg
No Relationships to Disclose
 
Christine Theodore
No Relationships to Disclose
 
Simon Chowdhury
No Relationships to Disclose
 
Sergio Bracarda
No Relationships to Disclose
 
Jessica Mary Clement
No Relationships to Disclose
 
Evan Y. Yu
Consulting or Advisory Role - Agensys; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen; Medivation; Merck; Sanofi; Seagen; Tokai Pharmaceuticals; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); GTx (Inst); Lilly/ImClone; Oncogenex (Inst)
Travel, Accommodations, Expenses - Exelixis; Lilly
 
Arash Rezazadeh Kalebasty
No Relationships to Disclose
 
Guenter Niegisch
Consulting or Advisory Role - Roche Pharma AG
Research Funding - 4SC
Travel, Accommodations, Expenses - Pfizer
 
Stephane Culine
No Relationships to Disclose
 
Michael S. Gordon
Stock and Other Ownership Interests - Caremission; Medelis
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Lilly/ImClone (Inst); MedImmune (Inst); Merck Serono (Inst); Millennium (Inst); OncoMed (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Na Cui
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Sanjeev Mariathasan
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Fatema A. Legrand
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Oyewale O. Abidoye
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Daniel Peter Petrylak
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; TYME
Honoraria - Astellas Pharma; Bayer; Bellicum Pharmaceuticals; Exelixis; Ferring; Genentech; Johnson & Johnson; Medivation; Merck Serono; Millennium; Pfizer; Progenics; Sanofi
Consulting or Advisory Role - Bayer; Bellicum Pharmaceuticals; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Astellas Medivation; Dendreon; Endocyte; Genentech; gtx; Johnson & Johnson; Merck; Millennium; Novartis; Oncogenex; progenics; Progenics; Sanofi
Expert Testimony - Celgene; sanofi
Travel, Accommodations, Expenses - Bayer; Bellicum Pharmaceuticals; Celgene; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Oncogenex; Pfizer; Progenics; Sanofi